Pipeline Programs↗
Distinct drugs in development (Preclinical–Phase 3)
Indications↗
Distinct diseases across all programs
Clinical Trials↗
All sponsored trials (all statuses)
Orange Book Patents
Across 1 drug with upcoming expirations
Pipeline
By Phase
1 drugs in development
By Therapeutic Area
top 1
R&D Momentum
12/100
Pipeline Velocity
6/100
Trial Completion Rate
N/A
Pipeline Concentration
100/100
Pipeline Freshness
94/100
Activity
Details
Company Overview
—
Mkt Cap
—
Revenue
—
Cash
Pipeline
Regulatory
Tenormin — TENORMIN
Application NDA019058 (NDA)
Tenormin — TENORMIN
Application NDA018240 (NDA)
Prinivil — ZESTRIL
Application NDA019777 (NDA)
Prinivil — PRINIVIL
Application NDA019558 (NDA)
Prinivil — QBRELIS
Application NDA208401 (NDA)
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)